About one in four adults experience chronic knee pain, though its prevalence continues to rise—even among younger people, according to 2019 research published in BMC Musculoskeletal Disorders. “It’s ...

This new CHIPS platform provides a crucial technological bridge between foundational FRESH™ 3D bioprinting capabilities and ...

The issuance of this patent marks another key milestone as FluidForm Bio continues to build a strong and defensible IP ...

The following is a summary of “Fluid balance and outcome in cardiac arrest patients admitted to intensive care unit,” ...

The global continuous renal replacement therapy market revenue was around US$ 1.5 billion in 2021 and is estimated to reach US$ 2.8 billion by 2031, growing at a compound annual growth rate (CAGR) of ...

FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced a major advancement in vascularized tissue engineering. A newly published study in ACS ...

A healthy diet and good sleep habits also support a smoother recovery. At Boston Medical Center, many patients follow a Rapid ...

The evidence is clear: Early physical therapy is essential for optimizing pain relief, restoring function, and minimizing healthcare costs following total knee replacement. Patients who engage in ...

The objective of this study is to evaluate the relationship between hormone replacement therapy (HRT) and the occurrence of CTS ... Metabolic tenosynovitis caused by diabetes, abnormalities of fluid ...

ALBANY, N.Y. — Dean Berhaupt has become the first patient to receive CAR T-cell therapy in Albany, marking a significant milestone for cancer treatment in the Capital Region. Berhaupt ...